Ignite Creation Date:
2025-12-24 @ 7:41 PM
Ignite Modification Date:
2025-12-30 @ 7:06 AM
Study NCT ID:
NCT06405503
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-08
First Post:
2023-04-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Impact of Primary Language on Treatment and Outcomes in Inflammatory Bowel Disease
Sponsor:
University of Texas at Austin
Organization:
Study Overview
Official Title:
Impact of Primary Language on Treatment and Outcomes in Inflammatory Bowel Disease
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A thorough discussion of treatment options to manage inflammatory bowel disease (IBD), including the risks and benefits of each class of medication, can be a complex discussion and time consuming. Having to use a translator adds an additional layer of time and complexity to these discussions as well as potential misunderstanding. Further, in addition to language, cultural differences can also play into treatment acceptance.
This study aims to determine the impact of primary language on the selection of treatment for IBD and on disease outcomes.
This study aims to determine the impact of primary language on the selection of treatment for IBD and on disease outcomes.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: